Dr Manmohan Singh was one of the rare Indian politicians whose inner goodness was evident to even his political and ...

NSE on Tuesday said that the decision to allow 6 new securities to join the F&O list comes after the stock selection criteria ...

The Securities and Exchange Board of India (Sebi ... journalist once quipped, “Dr. Singh’s idea of making a scene is adjusting his turban mid-sentence." The long list of his achievements ...

The National Stock Exchange (NSE) announced on Friday, December 20, the exclusion of futures and options (F&O) contracts for 16 securities, including Dr Lal Pathlabs ... from the list are Abbott ...

Stocks like Tata Steel, Dr Reddy’s Laboratories, WPIL, Rail Vikas Nigam, Mahindra and Mahindra, Mankind Pharma, CESC, Birlasoft, Puravankara, Maruti Suzuki India, Orissa Minerals Development Company, ...

Long-term Infrastructure like financing options at lower rates and higher payment periods along with tax breaks will help ...

Aster DM Healthcare director Anoop Moopen called for growing businesses to explore public listing in the stock market to ...

At the opening bell, the broader markets, activity remained subdued as the Nifty MidCap and SmallCap indices showed minimal ...

Dr Agarwal's Health Care, Casagrand Premier, Highway Infrastructure and Regreen-Excel EPC have received markets regulator ...

Dr Agarwal Health Care has received SEBI nod to raise funds through an initial public offering. The Company had filed its IPO papers with Sebi last September. The IPO will be a mix of a fresh ...

Dr. Manmohan Singh's humility, genuine interest in tribal issues, and integrity left a lasting impact on civil servant M.

Securities Exchange Board of India (SEBI) Chairperson Madhabi Puri Buch said on Friday the low-cost ₹250 systematic investment plan would be launched soon by mutual funds, aiding financial ...